BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche's New $152,850 Breast Cancer Drug     8/11/2014
Puma Biotechnology Shares Soar On Breast Cancer Drug Results     7/28/2014
Amgen, Bayer HealthCare's Nexavar Fails Late-Stage Breast Cancer Study     7/25/2014
Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials     7/24/2014
Celsion Corporation Announces Positive Interim Data Update From Its Phase 2 DIGNITY Study In Breast Cancer     7/24/2014
Pfizer Inc. Pursues Early Approval For Breast Cancer Drug     5/19/2014
Heat On Roche To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No"     4/23/2014
Stolen Roche Cancer Drug Found On Market     4/18/2014
Puma Biotechnology Plummets On Disappointing Breast Cancer Drug Results     4/9/2014
Pfizer Inc. Continues Its Streak, Phase 2 Breast Cancer Results Wows Investors And Researchers     4/8/2014
Curis, Inc. Announces Removal Of FDA Partial Clinical Hold On CUDC-427     3/31/2014
Roche Wins Battle Over Launch Of Biosimilar Version Of Its Breast Cancer Drug Herceptin     2/7/2014
Pfizer Inc.'s New Breast Cancer Treatment Succeeds In Phase 2 Trial     2/4/2014
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.), Astellas Pharma Inc. Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer     1/30/2014
BioCon Limited Hits Roche First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin     1/21/2014
 Featured Stories
Is Soy A Foe To Women With Breast Cancer? Memorial Sloan-Kettering Cancer Center Study     9/8/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study     8/4/2014
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study     7/28/2014
Association Found Between High Cholesterol And Breast Cancer, Aston University School Of Medical Sciences Study     7/7/2014
No Link Found Between Fertility Drugs And Cancers, University of Illinois Study     7/1/2014
Harmless Virus Kills Cancer And Tumor Cells, Pennsylvania State University Study     6/26/2014
Single Drug Could Soon Cure High Cholesterol, Breast Cancer, University of Missouri Study     6/19/2014
Red Meat Possibly Linked To Breast Cancer, Harvard School of Public Health Study     6/12/2014
Moles Linked To Breast Cancer Risk, Indiana University And Harvard University Study     6/11/2014
Can Mice Mimic Human Breast Cancer? Michigan State University Study Says "Yes"     6/6/2014
Antimicrobial Ingredient In Health Products Spurs Growth Of Breast Cancer Cells, American Chemical Society Reveals     4/25/2014
High-Fat Diets Linked To CertainTypes Of Breast Cancer, Fondazione IRCCS National Cancer Institute Study     4/23/2014
Body Mass Index, Not Body Shape Ups Breast Cancer Risk, American Cancer Society Reveals     4/21/2014
 More News
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial Of Folate Receptor Alpha Antigens In Ovarian And Breast Cancer     9/16/2014
Celsion Corporation (CLSN) Reports Consolidated Duke University And Celsion's DIGNITY Study Clinical Data On Thermodox® In Recurrent Chest Wall Breast Cancer Published In The International Journal Of Hyperthermia     9/5/2014
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment     9/2/2014
Pfizer Inc. (PFE) Release: Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With Hr+, Her2- Advanced Breast Cancer     8/21/2014
Research Study At Banner MD MD Anderson Cancer Center Tests New Drug To Fight BRCA-Associated Breast Cancer     8/20/2014
Pfizer Inc. (PFE) Announces Submission Of Palbociclib New Drug Application To The FDA     8/18/2014
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of HERMIONE, A Randomized Trial Of MM-302 In Patients With Advanced HER2-Positive Breast Cancer To Support Application For Accelerated Approval     8/11/2014
Susan G. Komen for the Cure And Northern Arizona (Komen CAN AZ) Selects And Retains Ideas Collide To Combat Breast Cancer     8/1/2014
CASI Pharmaceuticals  (ENMD) Receives Approval From CFDA To Conduct Phase 2 Clinical Trial With Enmd-2076 For Triple-Negative Breast Cancer In China     7/21/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE)     6/30/2014
AbbVie (ABBV) Announces Initiation Of Pivotal Phase 3 Study Of Veliparib (ABT-888) In Patients With Advanced Breast Cancer     6/26/2014
FDA Approves Bayer HealthCare (BAY)'s Gadavist (Gadobutrol) Injection As The First Magnetic Resonance Contrast Agent For Evaluation Of Breast Cancer In The United States     6/12/2014
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial     6/12/2014
Caris Life Sciences Research Provides Key Clinical Insights On Immunotherapeutic Targets In A Broad Range Of Cancers     6/10/2014
Caris Life Sciences Biomarker Research Suggests Role For Immune-Targeted Therapies In Subsets Of Patients With Triple Negative Breast Cancer (TNBC)     6/3/2014